Steven M. Blum, Thomas L. Chan, Neal P. Smith, Courtney Ambrose, Katherine H. Xu, Alice Tirard, Nandini Samanta, Sidney Martin, Roya Best, Elizabeth Tuttle, Christopher T. Stueber, Yuhui Song, Vaishnavi R. Yalala, Haley Barnes, Sean T. Bannon, Chloe Simms, Benjamin Y. Arnold, Mushriq Al-Jazrawe, Joseph J. Zhao, Kamil Slowikowski, Jessica Tantivit, Kasidet Manakongtreecheep, Lukas M. Altenburger, Simon Knott, Matthew R. Strickland, Michael G. Drage, Linda T. Nieman, Jesse S. Boehm, Raghav Sundar, Gary Reynolds, Samuel J. Klempner, Alexandra-Chloé Villani
{"title":"Multiomic analysis of malignant ascites defines RORC-expressing dendritic cells at sites of metastasis","authors":"Steven M. Blum, Thomas L. Chan, Neal P. Smith, Courtney Ambrose, Katherine H. Xu, Alice Tirard, Nandini Samanta, Sidney Martin, Roya Best, Elizabeth Tuttle, Christopher T. Stueber, Yuhui Song, Vaishnavi R. Yalala, Haley Barnes, Sean T. Bannon, Chloe Simms, Benjamin Y. Arnold, Mushriq Al-Jazrawe, Joseph J. Zhao, Kamil Slowikowski, Jessica Tantivit, Kasidet Manakongtreecheep, Lukas M. Altenburger, Simon Knott, Matthew R. Strickland, Michael G. Drage, Linda T. Nieman, Jesse S. Boehm, Raghav Sundar, Gary Reynolds, Samuel J. Klempner, Alexandra-Chloé Villani","doi":"10.1126/sciimmunol.aeb9068","DOIUrl":null,"url":null,"abstract":"<div >Malignant ascites is caused by the peritoneal dissemination of cancer and has a poor prognosis. Here, we performed multiomic analyses on ascites samples from patients with cancer and identified <i>RORC</i>-expressing dendritic cells (<i>RORC</i> DCs) enriched in malignant ascites. <i>RORC</i> DCs expressed <i>PIGR</i> and were transcriptionally similar to murine RORγt<sup>+</sup> DCs/Thetis cells implicated in immune tolerance. We devised a high-purity sorting strategy to enable in vitro experiments with patient-derived <i>RORC</i> DCs, which indicated that these cells were phenotypically stable and stimulated T cell proliferation while attenuating <i>IFNG</i> expression. Multiplexed immunofluorescence identified <i>RORC</i> DCs in primary tumors and demonstrated their enrichment in regional lymph node metastases. These results associate human <i>RORC</i> DCs with advanced malignancies and suggest a role for these cells in the tumor microenvironment.</div>","PeriodicalId":21734,"journal":{"name":"Science Immunology","volume":"11 124","pages":""},"PeriodicalIF":16.4000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/sciimmunol.aeb9068","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Malignant ascites is caused by the peritoneal dissemination of cancer and has a poor prognosis. Here, we performed multiomic analyses on ascites samples from patients with cancer and identified RORC-expressing dendritic cells (RORC DCs) enriched in malignant ascites. RORC DCs expressed PIGR and were transcriptionally similar to murine RORγt+ DCs/Thetis cells implicated in immune tolerance. We devised a high-purity sorting strategy to enable in vitro experiments with patient-derived RORC DCs, which indicated that these cells were phenotypically stable and stimulated T cell proliferation while attenuating IFNG expression. Multiplexed immunofluorescence identified RORC DCs in primary tumors and demonstrated their enrichment in regional lymph node metastases. These results associate human RORC DCs with advanced malignancies and suggest a role for these cells in the tumor microenvironment.
期刊介绍:
Science Immunology is a peer-reviewed journal that publishes original research articles in the field of immunology. The journal encourages the submission of research findings from all areas of immunology, including studies on innate and adaptive immunity, immune cell development and differentiation, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology. Additionally, the journal covers research on immune contributions to health and disease, such as host defense, inflammation, cancer immunology, autoimmunity, allergy, transplantation, and immunodeficiency. Science Immunology maintains the same high-quality standard as other journals in the Science family and aims to facilitate understanding of the immune system by showcasing innovative advances in immunology research from all organisms and model systems, including humans.